FDA Inspection 1021387 — Prisma Health Richland

Prisma Health Richland — FEI 1071758

The FDA completed an inspection of Prisma Health Richland on Aug 9, 2017 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 9, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Columbia, SC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.